T. Rowe Price Associates’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Buy |
+47,959
| New | +$106K | ﹤0.01% | 2882 |
|
|
2023
Q2 | – | Sell |
-17,100
| Closed | -$25K | – | 2932 |
|
|
2023
Q1 | $25K | Hold |
17,100
| – | – | ﹤0.01% | 2845 |
|
|
2022
Q4 | $40K | Hold |
17,100
| – | – | ﹤0.01% | 2834 |
|
|
2022
Q3 | $35K | Hold |
17,100
| – | – | ﹤0.01% | 2873 |
|
|
2022
Q2 | $38K | Hold |
17,100
| – | – | ﹤0.01% | 2882 |
|
|
2022
Q1 | $114K | Hold |
17,100
| – | – | ﹤0.01% | 2820 |
|
|
2021
Q4 | $95K | Buy |
17,100
+6,400
| +60% | +$35.6K | ﹤0.01% | 2880 |
|
|
2021
Q3 | $98K | Sell |
10,700
-4,800
| -31% | -$44K | ﹤0.01% | 2846 |
|
|
2021
Q2 | $172K | Sell |
15,500
-11,600
| -43% | -$129K | ﹤0.01% | 2754 |
|
|
2021
Q1 | $231K | Buy |
+27,100
| New | +$231K | ﹤0.01% | 2636 |
|